9999999997-13-000284.txt : 20130118 9999999997-13-000284.hdr.sgml : 20130118 20130118093332 ACCESSION NUMBER: 9999999997-13-000284 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130118 DATE AS OF CHANGE: 20130118 20130118 20130118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synthetic Biologics, Inc. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-12584 FILM NUMBER: 13536297 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE, STREET 2: SUITE 200 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0P(#`@;V)J#3P\+TQI;F5AF4@-3,O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(*)-A]@,0G7@8F1H;M(%D&1G3B/^.8F!@8&%@8(IF``*>V0RH@)$! M),O1@"S&`L4,##<8N!DXOUNQ+(`JE0N&T$PAR(H-ED%$&44!`@P`(SP&&0T* M96YD7!E+U!A9V4^/@UE;F1O8FH--#,@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I>[Q\M+>MTL\[(EG`E-I]G3I[Q8;UJBM:`?\LYTD3!#9]ML MW9!$TEE5MI-)]>OA0BF+-B(88YC@$:VS;%=L7]XMBEW>D-O\)[FK=EGY'FVW MV2ZG:'$&W/\ZOYA4V]67!=KG;9VWRPV]K>I=ML6M^XZ188S>M-FV6%Z7ZVU. M&)VW^>X;X8FFBY>G''V!52&6NKER=4#>X'/OZQW)9K8IR3>^+ M\KILBO`^*^JFG6ZRVGUR_QO0;==%^CGK'812=/[\HP4ZB_HY1UZ!G,N\:C?- M@S&6_$O`:"1)0I1RH\$8@L,16K?)HP8 M(=R0&5S]L^8\D$QLBK[P#+94RLX7WKV?>U=*[^7!0N*D2524LCP00Y(N6+K$ M?HWW0TS_;/MG;P\QCF@2V9!4WP"TIY((P7!5L*J^.2KBX4\@[ERWX;*&%PC! MDM00'J?PJ3OG$-43!&+@(?M.BA$!#R#K.1CION9M9MC#XF#/*0W8$]]4XYH@ M!V;=?A=OU``5'=(8X01Q)")@(1%"T($9![)^1,:`\0DG>0#@`TT:`Z8@1IB$ M0WEDNC^#O!7+H[Q78;'3'O!_$ MHN1R'FQ!FONX6'&E3H.8H-+VJAC4,1*@^%X)?X\/_:0X7G%/QHHK73\%/%NX MA_R@XH+?:<6%ZE%P.7\EN%X17@EN:L_0VXB!T5"Z#F/@]T[IK53)OM[RUWHK MHR,:`PKUO[XQ0LX>Q^*Q_?IX?B][AR05`-_^8[D]!B^WQ^'D]K<``P`W:7QO M#0IE;F1S=')E86T-96YD;V)J#30T(#`@;V)J#3P\+T9I;'1EXN60A>_/FXG+`>N>#NY!--S#!-M.J=UZ6(5.L?.@IS8(0 MIN$W"E.6A;DL4E8N>YR)\L_>U3O<[`4J*S!D@9(J8>7E"RNU6RG#,&+E%,XQ M3Y]9$,FBL`)FO1%_+Q(^A/\;H7EY=0E/[$X$BI=]>"RO[L3OY5LX$H2$N#^3 M18Y/LQ?.CNS9=*2F?>8!SE:QS-+FX7!2RJ]$D/#!^]L;$42\Q!=ZHFE:P/K# M2T:O'X0*^>!'$<2\/_Q!U'O9X!><>2>"'`9MMM-.&NB55@Q;QG2;$%L3,JE4 M4]NWXPJE['`8/XN8?V4J/V,Z5!$)[A:7.$3`_"CV`KN7IT<`3&21-!4BHVXO M"81;AGC<]L%W(1]Z&`DF1K,&IN&U*,PGL[&QMO\SP4D3M_!1);Q/+XBJ7;P/ MH8YE6!PC1':,$+`[VB/CT!I#QY*CC8N_D2FDW8%#M&!@;5U,5H7RD0=LS9WUD:AU,DI9Q=VN=(R+UJ1`?PBOFU%Q)_PX5Z8 MESGJ.847=H'FT^MJ0>.C^[8A.PCTV((>HT&Y<]B(GZ%8=H-@5!@]4]FV7JKH MF+W*I;D@V8N6%Y:[)!:D,HF;!E\+I8PI9`G:RH9`NY4T7N-AB!*YPC&1HB39L2SV9'ZE2$0=/8%N>H`2/9_5 MKB*_STP;>19!L4],O)Q9C[!8;L1"O:"NEL4RU`I=BUR MK_F2M8_*&\&N?4KXR6B0G0)[9`!=.+M:\H,(4D@SIP.?C+\OA:$B4@Y_B:H3 M`MNQ32MJ%;1A'5&]D%%Z-+LFC3P2I2>S:WH0\R[`+T1&P4!4-%&#VJ.&J!W. MK!UKW:**8J<=1/@9?&/L@YP16J2Z((7,HO]]9@GKI$+960$(/JE`V8IXA8B[ MHG6:;41M1H]S(MA)]K]41L$JU*81F9]\<[C`9F2.PP-"24_W&PJW\:;%JE@F M>\0<$8M6U8.M]#/'H\I[`7U":8K1:B+U MX^@HH_``NRU2:$WC@49H<0-5$FM3`GNB5Q>#;'9OMUL$?8&K3(020A#+(UZM M:*51>L76N\E^G5O4]3N"6)QY_:?6G2L3LZ2(+Z&2.1")1:B$V6UT?\3TN[`! M'`)H*."+LXM$[V:ULCAK-I]P''[&KS4;&HZ@C8NZ"02#5I^%+YG*YAE"Q&OR M1`LFM5FX`!HDVZZ!R_?[PTW][A:(U@+?&^Y?5D;\\QRYM3CH7Q*794WH6&=- MR":;7EU;VTK#M4L;*!QXESE`#UCK@771S]:64`;PF:DX!@G(H;GZYU#LYSYJ MR1*^IDO)%#/%7J*;X?RK@S2GDJ.U+FM>G<*35R>5OU3L7G[!BZ%JLR8W&-;= MH#*W#.GO&M"EQ4U92H9IIVSC&B+VCMCZ]&+QP(X!^7T_O5\B9%A*`X"Z6`>#40O(D3-TRM;_J%6V1QZX6OF>#ZN=;/LS0 MIF%<4B7&_[KJ[MN?2Y7YHM]L.DQ';8+A_\_>4UNUSB`@<8.YAHQ=';:1:WL? MZE$@RZ*^C8(V:P0_2"1FC)NIW]Q?=H8^*Q>WVSJEN]XFDZF];+PRH.OBJ,.4 MA(`\ZP.^Q]?3I-ZPX2.9M!D-B^LL*!4N]]NPJE M,LZ.FI=Z\V)Y!@9$1FEP'Z>@8V!F0$,$I.+ M"QP#`GQ`[+S\O%0&#/#M&@,CB+ZL"S(+4QXO8$TN*"H!T@>`V"@EM3@92'\! MXLSRD@*@.&,"D"V2E`UF@]2)9(<$.0/9'4`V7TEJ!4B,P3F_H+(H,SVC1,'0 MTM)2P3$E/RE5(;BRN"0UMUC!,R\YOZ@@ORBQ)#4%J!9J!PCPNQ`P8A0[CQ!#@.32HC(HDY')F($!(,``2<8X+PT* M96YD==_$.D_$GZI`8J\!`(`F!T$($L@:V@KB)8"TWD0/#(0>!K#@<^ M<-00+$<#P7$PPG,$B.6_")$B8`6QX;`0F8+(6*H`"[ZQ@(XS(F#-ZW`1&\[: M`7K.4`,&7ICQ965T'OA7BS[P_G@GO`@QCUP%Q#SR%HAYKD(@YCDN$O-I MG;JA-[NQ[-6.OX;7_0/_F\RZ?&Y8V^_1 ME_ZYZ]/NL66UI]G?YJG49!76W3VE89Y.P_G'ZR%WXWDXIOQG8<]7]VEX,Y>\ MM>_]0\IGTFKU?]_2\G0KOJO3\SV"P].M;>05\GO5NJAV2>TZM5NKW4;M>K4; MU&[4;7P@2[=E=5U6]V5U858W9G5E5G=F=6E6MX:Z-?S@C>G64+>&NC74K>$_ MK?T48``:JY'>#0IE;F1S=')E86T-96YD;V)J#3(@,"!O8FH-/#PO3&5N9W1H M(#,X-S8O4W5B='EP92]834PO5'EP92]-971A9&%T83X^G)E4WI.5&-Z:V,Y M9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM M<'1K/2)!9&]B92!835`@0V]R92`U+C(M8S`P,2`V,RXQ,SDT,SDL(#(P,3`O M,#DO,C&UP.DUE=&%D871A1&%T93XR,#$S+3`Q+3$X5#`Y M.C,Q.C4R+3`U.C`P/"]X;7`Z365T861A=&%$871E/@H@("`@("`@("`\>&UP M.D-R96%T;W)4;V]L/D%C&UP.D-R96%T;W)4;V]L/@H@("`@("`\+W)D9CI$97-C&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B M/@H@("`@("`@("`\>&UP34TZ1&]C=6UE;G1)1#YU=6ED.F4U,6,Y,CDR+3%A M8S$M-#EE8BTX.61A+3=B9#!E93!F.#$S9CPO>&UP34TZ1&]C=6UE;G1)1#X* M("`@("`@("`@/'AM<$U-.DEN&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R M9R]D8R]E;&5M96YT&UL M;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@ M("`@/'!D9CI02`Q,"XP/"]P9&8Z M4')O9'5C97(^"B`@("`@(#PO,K90,%"PL=%WSB_-*U$PU/?.3"F.-C$""@;%ZH=4%J3J!R2FIQ;; MV0$$&`#H8@OC#0IE;F1S=')E86T-96YD;V)J#30@,"!O8FH-/#PO1FEL=&5R M+T9L871E1&5C;V1E+T9I'ET"PFJ5;8+O6)(PI-F6[P_3CTE-;1#G'0U@>@N[9V?Z M*T&\[VX8'/KMF4@-#`O5'EP92]8 M4F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F(``B9&_DX&)@:F$"`A4`@D&/J` M!*,H4.*>`(C+P#AH"::'0(*1`2#``$O9!%<-"F5N9'-T